ABSA International
ABSA International

Resources with keywords: poxvirus

Training Tools & Resources
EIDC Toolboxes


Risk communication and community engagement (RCCE) for monkeypox outbreaks: Interim guidance, 24 June 2022
WHO
keywords: Monkeypox, poxvirus, risk communication, WHO
Notice of Enforcement Discretion Regarding Monkeypox Medical Waste
DOT

Discusses handling of medical waste based on whether testing indicates it is from the West African clade (Cat. B) or the Congo Basin clade (Cat. A)

keywords: medical waste, Monkeypox, poxvirus
Monkeypox Update: FDA Authorizes Emergency Use of JYNNEOS Vaccine to Increase Vaccine Supply
FDA

For individuals 18 years of age and older determined to be at high risk of monkeypox infection, the EUA now allows for a fraction of the JYNNEOS dose to be administered between the layers of the skin (intradermally).

keywords: JYNNEOS, Monkeypox, poxvirus, vaccines
08/23/2022: Lab Advisory: Monkeypox Virus Testing Considerations to Prevent False Positive Test Results
CDC/Laboratory Outreach Communication System (LOCS)

Worldwide, there have been no reports of transmission of monkeypox virus through blood transfusion and the risk of transfusion-transmission remains theoretical.

keywords: Monkeypox, poxvirus, testing
Information for Blood Establishments Regarding the Monkeypox Virus and Blood Donation
FDA
keywords: blood safety, Monkeypox, poxvirus, testing
Strategies Adopted by Gay, Bisexual, and Other Men Who Have Sex with Men to Prevent Monkeypox virus Transmission — United States, August 2022
CDC/MMWR
2 September 2022

Delaney KP, Sanchez T, Hannah M, et al.

keywords: Monkeypox, poxvirus, prevention, transmission
Monkeypox Pill Puts Drugmaker on the Map
Wall Street Journal (WSJ)
26 August 2022
keywords: Monkeypox, poxvirus, Tpoxx, treatment
Monkeypox: The State of the Science
American Public Health Association (APHL)/National Academy of Medicine
24 August 2022
keywords: epidemiology, Monkeypox, poxvirus, symptoms, treatment, vaccination
Safety Alert Regarding Use of Fecal Microbiota for Transplantation and Additional Safety Protections Pertaining to Monkeypox Virus
FDA
22 August 2022

The FDA is informing health care providers of the potential risk of transmission of monkeypox virus through fecal microbiota for transplantation (FMT) products– additional safety protections are needed.

keywords: fecal microbiota, Monkeypox, poxvirus, transplant
What You Need To Know About Monkeypox
Science Friday
12 August 2022

The interview discusses modes transmission, communication, and vaccination.

keywords: Monkeypox, podcast, poxvirus, transmission, vaccination

Not a member and would like updates and notifications?

ABSA International
1200 Allanson Road, Mundelein, IL 60060-3808
1-866-425-1385 (toll free) or 847-949-1517
info@absa.org | Contact ABSA

ABOUT | MEMBERSHIP | NEWS/COMMUNITY | RESOURCES | PUBLICATIONS | CREDENTIALS | PROFESSIONAL DEVELOPMENT

For a complete view of the web presence of ABSA International, see the ABSA Portal page.

Copyright © ABSA International. All Rights Reserved.  Privacy Policy

ABSA International does not endorse, promote, review, or warrant the accuracy of the products and services offered by those parties who link to the ABSA International website. The links are merely provided as a convenience to the visitors of this site, and ABSA International may or may not be compensated for permitting the link to be displayed on this page.

Go to Top